New York State Common Retirement Fund’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$674K Sell
46,228
-53,646
-54% -$518K ﹤0.01% 1894
2026
Q1
$741K Buy
99,874
+63,446
+174% +$668K ﹤0.01% 1767
2025
Q4
$428K Hold
36,428
﹤0.01% 2017
2025
Q3
$281K Hold
36,428
﹤0.01% 2145
2025
Q2
$266K Sell
36,428
-3,323
-8% -$26.8K ﹤0.01% 2133
2025
Q1
$377K Buy
39,751
+3,323
+9% +$41.5K ﹤0.01% 1986
2024
Q4
$600K Hold
36,428
﹤0.01% 1879
2024
Q3
$537K Sell
36,428
-67,100
-65% -$1.05M ﹤0.01% 1920
2024
Q2
$1.44M Buy
103,528
+17,389
+20% +$247K ﹤0.01% 1602
2024
Q1
$1.35M Buy
86,139
+7,047
+9% +$109K ﹤0.01% 1633
2023
Q4
$1.28M Sell
79,092
-4,970
-6% -$81.3K ﹤0.01% 1665
2023
Q3
$1.03M Sell
84,062
-131,134
-61% -$1.95M ﹤0.01% 1731
2023
Q2
$3.46M Sell
215,196
-42,586
-17% -$702K ﹤0.01% 1316
2023
Q1
$4.49M Buy
257,782
+136,667
+113% +$1.95M 0.01% 1219
2022
Q4
$1.12M Buy
121,115
+3,077
+3% +$28.7K ﹤0.01% 1911
2022
Q3
$1.02M Buy
118,038
+8,117
+7% +$80.6K ﹤0.01% 1962
2022
Q2
$896K Sell
109,921
-457,346
-81% -$4.37M ﹤0.01% 2073
2022
Q1
$6.89M Sell
567,267
-250,862
-31% -$5.28M 0.01% 1134
2021
Q4
$27.9M Sell
818,129
-159,384
-16% -$6.24M 0.03% 512
2021
Q3
$47.2M Sell
977,513
-11,285
-1% -$522K 0.05% 342
2021
Q2
$44.7M Sell
988,798
-675
-0.1% -$29.9K 0.05% 358
2021
Q1
$47.7M Buy
989,473
+14,067
+1% +$732K 0.05% 328
2020
Q4
$52.5M Sell
975,406
-6,958
-0.7% -$314K 0.06% 306
2020
Q3
$36.2M Sell
982,364
-1,200
-0.1% -$44.6K 0.04% 379
2020
Q2
$30.5M Buy
983,564
+162,583
+20% +$4.51M 0.04% 431
2020
Q1
$22.7M Sell
820,981
-13,411
-2% -$402K 0.03% 476
2019
Q4
$24.4M Buy
834,392
+129,253
+18% +$3.08M 0.03% 572
2019
Q3
$13.5M Buy
705,139
+87,289
+14% +$2.05M 0.02% 821
2019
Q2
$13.6M Buy
617,850
+79,617
+15% +$1.75M 0.02% 847
2019
Q1
$11M Sell
538,233
-12,944
-2% -$225K 0.01% 919
2018
Q4
$6.95M Sell
551,177
-7,003
-1% -$104K 0.01% 1042
2018
Q3
$8.57M Sell
558,180
-127,349
-19% -$1.76M 0.01% 1076
2018
Q2
$8.99M Buy
685,529
+6,050
+0.9% +$66.6K 0.01% 1060
2018
Q1
$5.54M Sell
679,479
-27,650
-4% -$224K 0.01% 1200
2017
Q4
$6.26M Sell
707,129
-31,652
-4% -$292K 0.01% 1163
2017
Q3
$8.22M Buy
738,781
+109,245
+17% +$1.06M 0.01% 1031
2017
Q2
$5.64M Buy
629,536
+49,890
+9% +$396K 0.01% 1216
2017
Q1
$4.57M Sell
579,646
-15,781
-3% -$129K 0.01% 1296
2016
Q4
$5.1M Buy
595,427
+77,413
+15% +$663K 0.01% 1245
2016
Q3
$4.26M Hold
518,014
0.01% 1289
2016
Q2
$4.17M Hold
518,014
0.01% 1304
2016
Q1
$3.49M Buy
518,014
+6,057
+1% +$39.9K 0.01% 1364
2015
Q4
$4.03M Buy
511,957
+13,509
+3% +$98.9K 0.01% 1312
2015
Q3
$2.86M Buy
498,448
+20,145
+4% +$125K ﹤0.01% 1442
2015
Q2
$2.59M Buy
478,303
+22,753
+5% +$117K ﹤0.01% 1727
2015
Q1
$2.13M Buy
455,550
+53,138
+13% +$231K ﹤0.01% 1627
2014
Q4
$1.68M Buy
402,412
+184,172
+84% +$846K ﹤0.01% 1678
2014
Q3
$1.14M Buy
+218,240
New +$1.12M ﹤0.01% 1819

Other funds holding NEO

New York State Common Retirement Fund's NEO Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its NeoGenomics (NEO) stake by 54% in Q2 2026, selling an estimated $518K and leaving 46,228 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

New York State Common Retirement Fund first reported a position in NEO in Q3 2014 and has held it in 48 quarters since. The position peaked at $52.5M in Q4 2020. 72 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • New York State Common Retirement Fund held 46,228 shares of NeoGenomics worth $674K as of Q2 2026.
  • New York State Common Retirement Fund sold 53,646 NeoGenomics shares in Q2 2026, an estimated $518K.
  • NeoGenomics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1894 holding.
  • New York State Common Retirement Fund first reported a position in NeoGenomics in Q3 2014 and has held it in 48 quarters since.
  • New York State Common Retirement Fund's NeoGenomics position peaked at $52.5M in Q4 2020.
  • 72 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.